Treatment reverses symptoms of type 2 diabetes in mice without side effects.
In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days.
The discovery by Salk scientists, published today in the journal Nature, could lead to a new generation of safer, more effective diabetes drugs.
The team found that sustained treatment with the protein doesn’t merely keep blood sugar under control, but also reverses insulin insensitivity, the underlying physiological cause of diabetes. Equally exciting, the newly developed treatment doesn’t result in side effects common to most current diabetes treatments.
“Controlling glucose is a dominant problem in our society,” says Ronald M. Evans, director of Salk’s Gene Expression Laboratory and corresponding author of the paper. “And FGF1 offers a new method to control glucose in a powerful and unexpected way.”
The Latest on: FGF1
[google_news title=”” keyword=”FGF1″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: FGF1
- AIMRC Seminar: Characterization of Mitogenic and Metabolic Fibroblast Growth Factors, Lessons Learnedon April 15, 2024 at 5:34 am
Professor Suresh Thallapuranam, director of the AIMRC Bioenergetics Core at the U of A, will give a lecture at 12:55 p.m. Wednesday in Gearhart Hall 108.
via Bing News